Tenofovir (Viread): Research
- Pharmacokinetic Parameters of Atazanavir/Ritonavir When Combined to Tenofovir in HIV Infected Patients With Multiple Treatment Failures: A Substudy of Puzzle2-ANRS 107 Trial (February 12, 2003)
In The 10th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Tenofovir Disoproxil Fumarate and Lamivudine Combination Therapy Compared to Lamivudine Alone for HBV in Therapy-Naive HIV/HBV Co-Infected Patients: 48-Week Interim Results (February 12, 2003)
In The 10th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Efficacy and Safety of Tenofovir DF Versus Stavudine When Used in Combination With Lamivudine and Efavirenz in Antiretroviral-Naive Patients: 96-Week Preliminary Interim Results (February 11, 2003)
In The 10th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Research From the 42nd ICAAC: A Nucleoside (FTC) and a Nucleotide (Tenofovir) Outdo d4T (December 2002)
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Research From the 42nd ICAAC: Tenofovir Intensification Allies: Low Load, No TAMs, M184V (December 2002)
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Safety Profile of Tenofovir DF in Treatment-Experienced Patients From Randomized, Placebo-Controlled Clinical Trials (November 21, 2002)
In The 6th International Congress on Drug Therapy in HIV Infection, from TheBodyPRO.com
- Pharmacokinetics Following Single Doses Administrations of Tenofovir DF in Subjects With Renal Impairment (November 21, 2002)
In The 6th International Congress on Drug Therapy in HIV Infection, from TheBodyPRO.com
- The Development of K65R Versus Thymidine Analogue-Associated Mutations in Antiviral-Treated Patients (November 21, 2002)
In The 6th International Congress on Drug Therapy in HIV Infection, from TheBodyPRO.com
- Genotypic and Phenotypic Characterization of Virologic Failure Through 48 Weeks Among Treatment-Naive Patients Taking Tenofovir DF or Stavudine in Combination With Lamivudine and Efavirenz (November 21, 2002)
In The 6th International Congress on Drug Therapy in HIV Infection, from TheBodyPRO.com
- Tenofovir DF and Didanosine EC: Investigation of Pharmacokinetic Drug-Drug and Drug-Food Interactions (November 21, 2002)
In The 6th International Congress on Drug Therapy in HIV Infection, from TheBodyPRO.com
- Comparison of the Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Stavudine When Used in Combination With Lamivudine and Efavirenz in HIV-1 Infected Patients Naive to Antiretroviral Therapy After 48 Weeks of Treatment (November 21, 2002)
In The 6th International Congress on Drug Therapy in HIV Infection, from TheBodyPRO.com
- Successful Switch From Stavudine to Once-Daily Tenofovir Based Regimen in Patients With Fully Suppressed HIV (October 26, 2002)
In 40th Annual Meeting of the Infectious Diseases Society of America, from TheBodyPRO.com
- Viread-Videx EC Drug Interactions -- What's a Person to Do? (Fall 2002)
To read PDF, click here.
In STEP Perspective, from Seattle Treatment Education Project
On TheBodyPRO.com
- Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Stavudine When Used in Combination With Lamivudine and Efavirenz in HIV-1 Infected Patients Naive to Antiretroviral Therapy: 48-Week Interim Results (July 12, 2002)
In The XIV International AIDS Conference, from TheBodyPRO.com
- Expanded Response Analyses of Tenofovir DF Therapy by Baseline Resistance Genotype and Phenotype (July 11, 2002)
In The XIV International AIDS Conference, from TheBodyPRO.com
- Tenofovir DF and Didanosine EC: Investigation of Pharmacokinetic Drug-Drug and Drug-Food Interactions (July 11, 2002)
In The XIV International AIDS Conference, from TheBodyPRO.com
- Tenofovir DF: A 48-Week Final Analysis From a Phase III Randomized, Double Blind, Placebo Controlled Study in Antiretroviral Treatment-Experienced Patients (July 10, 2002)
In The XIV International AIDS Conference, from TheBodyPRO.com
- Anti-Hepatitis B Virus Activity of Tenofovir Disoproxil Fumarate in Lamivudine Experienced HIV/HBV Co-Infected Patients (July 10, 2002)
In The XIV International AIDS Conference, from TheBodyPRO.com
- Safety Profile of Tenofovir DF in Antiretroviral Treatment-Experienced Patients From Randomized, Double-Blind, Placebo-Controlled Clinical Trials (July 9, 2002)
In The XIV International AIDS Conference, from TheBodyPRO.com
- Efficacy of Tenofovir DF Monotherapy in Chronically HIV-1 Infected Antiretroviral Treatment-Naive Patients (July 9, 2002)
In The XIV International AIDS Conference, from TheBodyPRO.com
- Retrospective Analysis of the Use of Tenofovir DF in a Private Practice (July 8, 2002)
In The XIV International AIDS Conference, from TheBodyPRO.com
|
Advertisement
|
Email
Glossary
